Survival in patients with hepatocellular carcinoma treated with intra-arterial I-131 labelled lipiodol

GI Cancer

Volumn 3, Issue 5, 2001, Pages 359-369

  Butler, S Patrick ^a   Morris, David L ^a   King, Julie ^a   McKay, Erin ^a   Parkes, Sharon L ^a   Ring, Michelle T ^a  

^a ST GEORGE HOSPITAL   (Australia)

Author keywords

Hepatoceltutar Carcinoma; Iodine 131; Lipiodol

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; IODINATED POPPYSEED OIL; IODINE 131;

ADULT; AGED; ARTICLE; BIOPSY; BONE SCINTISCANNING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; DRUG EFFICACY; FEMALE; FOLLOW UP; HEPATIC ARTERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER SCINTISCANNING; MALE; MORTALITY; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0035688007     PISSN: 10649700     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. The natural history of hepatocellular carcinoma
2. Natural history of hepatocellular carcinoma prognosis in relation to treatment
3. Randomised trial of targeted chemotherapy with lipiodol 5-epidoxorubicin compared with symptomatic treatment for hepatoma
4. Comparison of resection, liver transplantation and transcatheter oily chembolization in the treatment of hepatocellular carcinoma
5. Therapeutic aspects of radioisotopes in hepatobiliary malignancy
6. A 5 year study of cryosurgery in the treatment of liver tumours
7. Percutaneous interstitial laser therapy of a patient with recurrent hepatoma in a transplanted liver
8. Iodized oil in the treatment of hepatocellular carcinoma
9. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma-a randomized controlled trial
10. Transcatheter arterial embolization in hepatocellular carcinoma
11. Hepatocellular carcinoma: Treatment with percutaneous ethanol injection and transcatheter arterial embolization
12. A phase I study of Yttrium-90 antiferritin I: Dose escalation and tumour dose
13. Immunoradiotherapy for primary non resectable hepatocellular carcinoma
14. Preparation of I-131 lipiodol as a hepatoma therapeutic agent
15. Preliminary validation of the opposing view method for quantitative gamma camera imaging
16. MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine
17. Pulmonary toxicity following lipiodol I-131 treatment for liver tumours
18. Internal radiation therapy for hepatocellular carcinoma injection of iodine 131-labeled lipiodol
19. Selective internal radiation therapy with intra-arterial iodine-131-lipiodol in inoperable hepatocellular carcinoma
20. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil
21. Epirubicin-Lipiodol chemotherapy versus 131-iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma
22. Superselective intra-arterial radiometabolic therapy with I-131 lipiodol in hepatocellular carcinoma
23. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis intra-arterial iodine-131-iodized oil versus medical support
24. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
25. Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results of a western comparative study in 60 patients
26. Nodular hepatocellular carcinoma-treatment with intraarterial injection of I-131 lipiodol
27. Limitations of hyperselective intraarterial injections for the treatment of hepatocellular carcinoma
28. Efficacy of lipiodol I-131: Response of treated and untreated hepatocellular carcinoma within the same liver
29. Publication 44. Protection of the patient in radiation therapy
30. Risk from deterministic effects of ionising radiation